Literature DB >> 11226229

Viral capsid mobility: a dynamic conduit for inactivation.

K Broo1, J Wei, D Marshall, F Brown, T J Smith, J E Johnson, A Schneemann, G Siuzdak.   

Abstract

Mass spectrometry and fluorescent probes have provided direct evidence that alkylating agents permeate the protein capsid of naked viruses and chemically inactivate the nucleic acid. N-acetyl-aziridine and a fluorescent alkylating agent, dansyl sulfonate aziridine, inactivated three different viruses, flock house virus, human rhinovirus-14, and foot and mouth disease virus. Mass spectral studies as well as fluorescent probes showed that alkylation of the genome was the mechanism of inactivation. Because particle integrity was not affected by selective alkylation (as shown by electron microscopy and sucrose gradient experiments), it was reasoned that the dynamic nature of the viral capsid acts as a conduit to the interior of the particle. Potential applications include fluorescent labeling for imaging viral genomes in living cells, the sterilization of blood products, vaccine development, and viral inactivation in vivo.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11226229      PMCID: PMC30128          DOI: 10.1073/pnas.051598298

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  15 in total

1.  Maturation cleavage required for infectivity of a nodavirus.

Authors:  A Schneemann; W Zhong; T M Gallagher; R R Rueckert
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

2.  Application of agar-gel diffusion analysis to a study of the antigenic structure of inactivated vaccines prepared from the virus of foot-and-mouth disease.

Authors:  F BROWN; J CRICK
Journal:  J Immunol       Date:  1959-05       Impact factor: 5.422

3.  Evidence of viral capsid dynamics using limited proteolysis and mass spectrometry.

Authors:  B Bothner; X F Dong; L Bibbs; J E Johnson; G Siuzdak
Journal:  J Biol Chem       Date:  1998-01-09       Impact factor: 5.157

4.  Chemical modification of viral ribonucleic acid. 8. The chemical and biological effects of methylating agents and nitrosoguanidine on tobacco mosaic virus.

Authors:  B Singer; H Fraenkel-Conrat
Journal:  Biochemistry       Date:  1969-08       Impact factor: 3.162

5.  Synthesis of Black Beetle Virus Proteins in Cultured Drosophila Cells: Differential Expression of RNAs 1 and 2.

Authors:  P D Friesen; R R Rueckert
Journal:  J Virol       Date:  1981-03       Impact factor: 5.103

6.  Nanoelectrospray mass spectrometry and precursor ion monitoring for quantitative steroid analysis and attomole sensitivity.

Authors:  K Chatman; T Hollenbeck; L Hagey; M Vallee; R Purdy; F Weiss; G Siuzdak
Journal:  Anal Chem       Date:  1999-07-01       Impact factor: 6.986

Review 7.  'Flu' and structure-based drug design.

Authors:  R C Wade
Journal:  Structure       Date:  1997-09-15       Impact factor: 5.006

8.  Antiviral agent blocks breathing of the common cold virus.

Authors:  J K Lewis; B Bothner; T J Smith; G Siuzdak
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-09       Impact factor: 11.205

9.  Poliovirus neutralization by antibodies to internal epitopes of VP4 and VP1 results from reversible exposure of these sequences at physiological temperature.

Authors:  Q Li; A G Yafal; Y M Lee; J Hogle; M Chow
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

Review 10.  What clinicians need to know about antiviral drugs and viral resistance.

Authors:  R L Hodinka
Journal:  Infect Dis Clin North Am       Date:  1997-12       Impact factor: 5.982

View more
  15 in total

1.  Picornaviruses.

Authors:  Tobias J Tuthill; Elisabetta Groppelli; James M Hogle; David J Rowlands
Journal:  Curr Top Microbiol Immunol       Date:  2010       Impact factor: 4.291

2.  The vault exterior shell is a dynamic structure that allows incorporation of vault-associated proteins into its interior.

Authors:  Michael J Poderycki; Valerie A Kickhoefer; Catherine S Kaddis; Sujna Raval-Fernandes; Erik Johansson; Jeffrey I Zink; Joseph A Loo; Leonard H Rome
Journal:  Biochemistry       Date:  2006-10-03       Impact factor: 3.162

3.  A 38-amino-acid sequence encompassing the arm domain of the cucumber necrosis virus coat protein functions as a chloroplast transit Peptide in infected plants.

Authors:  Yu Xiang; Kishore Kakani; Ron Reade; Elizabeth Hui; D'Ann Rochon
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

4.  Kinetic models for receptor-catalyzed conversion of coxsackievirus B3 to A-particles.

Authors:  Steven D Carson
Journal:  J Virol       Date:  2014-07-30       Impact factor: 5.103

5.  Molecular determinants of enterovirus 71 viral entry: cleft around GLN-172 on VP1 protein interacts with variable region on scavenge receptor B 2.

Authors:  Pan Chen; Zilin Song; Yonghe Qi; Xiaofeng Feng; Naiqing Xu; Yinyan Sun; Xing Wu; Xin Yao; Qunyin Mao; Xiuling Li; Wenjuan Dong; Xiaobo Wan; Niu Huang; Xinliang Shen; Zhenglun Liang; Wenhui Li
Journal:  J Biol Chem       Date:  2012-01-04       Impact factor: 5.157

6.  Capsid structure and dynamics of a human rhinovirus probed by hydrogen exchange mass spectrometry.

Authors:  Lintao Wang; David L Smith
Journal:  Protein Sci       Date:  2005-05-09       Impact factor: 6.725

7.  Chemical reactivity of brome mosaic virus capsid protein.

Authors:  W E Running; P Ni; C C Kao; J P Reilly
Journal:  J Mol Biol       Date:  2012-06-28       Impact factor: 5.469

8.  Pocket factors are unlikely to play a major role in the life cycle of human rhinovirus.

Authors:  Umesh Katpally; Thomas J Smith
Journal:  J Virol       Date:  2007-04-11       Impact factor: 5.103

9.  Albumin Enhances the Rate at Which Coxsackievirus B3 Strain 28 Converts to A-Particles.

Authors:  Steven D Carson; Andrew J Cole
Journal:  J Virol       Date:  2020-02-28       Impact factor: 5.103

10.  Viral uncoating is directional: exit of the genomic RNA in a common cold virus starts with the poly-(A) tail at the 3'-end.

Authors:  Shushan Harutyunyan; Mohit Kumar; Arthur Sedivy; Xavier Subirats; Heinrich Kowalski; Gottfried Köhler; Dieter Blaas
Journal:  PLoS Pathog       Date:  2013-04-04       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.